Bio Protocol vs Propy — how do they compare? Bio Protocol trades at Rp437.65 (market cap Rp995,56M, Rp174,03M 24h volume), while Propy trades at Rp5,997 (market cap Rp603,74M, Rp14,03M 24h volume). The key difference: Bio Protocol is the larger of the two by market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Propy's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Propy for 7 Days on average.
| BIO | PRO | |
|---|---|---|
Market Cap | Rp995,56M | Rp603,74M |
Volume (24h) | Rp174,03M | Rp14,03M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 100M PRO |
Typical Hold Time | 18 Days | 7 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
Propy (PRO) is trading at Rp6,072.132 with a market cap of Rp596.88 million, showing neutral technical signals overall. The moving averages indicate a bullish trend, while oscillators are neutral. Key support and resistance levels are tightly clustered around the current price, suggesting consolidation. Recent on-chain activity shows a hold time of 7 days, indicating moderate holder confidence. No major protocol updates or ecosystem developments were reported recently, keeping fundamental drivers subdued.
The outlook for PRO is neutral with limited near-term catalysts. Opportunities include potential breakout above resistance levels if buying pressure increases. Major risks involve low liquidity, high volatility typical of small-cap cryptocurrencies, and regulatory uncertainties in the crypto space. Investors should monitor trading volume changes and broader market sentiment for directional cues.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Propy is a blockchain-powered platform digitizing property titles and automating real estate transactions through smart contracts. It enables crypto-native payments while reducing fraud, paperwork, and settlement delays. The PRO token supports rewards, governance, and fee payments within the ecosystem.
Read more on PRO →